Dr. Jason Konner discusses psilocybin, clinician burnout, CIPN prevention, and safety protocols for oncology nurses and care teams in cancer care.
|Articles|June 15, 2019
Pursuing Charlene's Dream
Author(s)Brielle Benyon
Oncology nursing is more than just a job to Barbara Bittner, RN, OCN.
Advertisement
Barbara Bittner, RN, OCN, is an oncology nurse navigator at AdventHealth in Florida. But to her, nursing is much more than just a career. Bittner cares deeply for all of her patients, and even helped establish Charlene's Dream, a resource center for women with cancer, after her friend and Colleague, Charlene, passed away from the disease.
Advertisement
Related to this article
FDA approves belzutifan with lenvatinib for advanced clear cell RCC after PD-1/PD-L1 inhibitor failure. Review LITESPARK-011 data and nursing takeaways.
ANA President Jennifer Mensik Kennedy outlines systemic nurse fatigue mitigation policies, emphasizing patient safety and acuity across oncology care.
From ICN 2026, Heather Jackson and Ashley Johnson detail APP breast care access models, global cancer pain barriers, and burnout mitigation tactics.
FDA approves lirafugratinib (Lyrfigtu) for FGFR2+ cholangiocarcinoma. Review REFOCUS trial data, 70 mg daily dosing, and nursing safety guidelines.
Beth Faiman, PhD, and Sikander Ailawadhi, MD, discuss clinical trials and nursing impacts of on-body isatuximab delivery in multiple myeloma.
Yesne Alici, MD, of Memorial Sloan Kettering Cancer Center discusses key delirium screening, patient capacity, and bioethics in oncology nursing care.
A nurse-led support program significantly reduces death anxiety in women with breast cancer on hormonal therapy, study finds.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Belzutifan Plus Lenvatinib for Advanced Clear Cell RCC
2
Reframing Nurse Fatigue as Systemic Safety Risk
3
FDA Approves Lirafugratinib for Advanced FGFR2+ Cholangiocarcinoma
4
ICN 2026: APP Leadership, Cancer Pain Care, and Nurse-Led Rapid Care Models
5